CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 306 enrolled
Drug / intervention
DreamKitdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04671342
NCT04671342N/ACompleted

Diagnostic Validation of the DreamKit Device Against Polysomnography

Philips Clinical & Medical Affairs Global·interventional·Posted Dec 17, 2020·Updated Jan 31, 2023

In Brief

A clinical study evaluating DreamKit for Sleep Apnea, Obstructive and Sleep Apnea, Central. Completed, enrolled 306 participants across 7 sites.

Detailed Summary

This study has been developed in order to demonstrate diagnostic efficacy of the DreamKit device against polysomnography.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 17, 2020
Enrollment StartJan 14, 2021
Primary CompletionDec 18, 2021
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.5 years ago

Interventions

DreamKitdevice

The DreamKit device is a single-use device intended to aid the diagnosis of sleep-disordered breathing.